A 17-year-old girl arrived on a stretcher to write the exam in a government school in Ganapathipalayam. (Photo | EPS) 
Tamil Nadu

Student arrives on stretcher for exam in Tiruppur

It was diagnosed that she was suffering from obstruction of blood to the abdominal and other internal organs.

Express News Service

TIRUPPUR: In a show of willpower, a 17-year-old girl arrived on a stretcher to write the exam in a government school in Ganapathipalayam on Thursday.

Speaking to TNIE, Dr V Arul Jyothi, medical director of a private hospital, said, “Rithanya (17), a resident of Kuppandampalayam, developed severe abdominal pain and was admitted to our hospital on May 2. It was diagnosed that she was suffering from obstruction of blood to the abdominal and other internal organs. As the condition, necessitated immediate medical intervention, we performed laparoscopic surgery in our facility on May 3.”

“We advised her bed rest, but she was keen to write the exam and her parents stood by her. We were surprised by the willpower and determination of the student. So, we decided to send her in an ambulance to the school which was 4 km away. A medical team with a doctor and nurse was also sent to monitor the patient inside the school. She completed the exam and returned to the hospital in the afternoon. We advised complete bed rest in our facility,” he added.

Around 25,715 students from 218 higher secondary schools in Tiruppur district wrote the Class 12 exam held at 91 exam centres. While 25,348 students wrote Tamil (language) paper, 361 wrote French and Six wrote Hindi. At least 1,503 students were absent.

Why the additional declaration linked to Form 6 is facing a legal challenge

SP-Congress alliance faces fresh strain as Akhilesh skips INDIA bloc meet over UP seat-sharing talks

Rahul Gandhi tells CWC to continue 'resistance' against 'match-fixing' of polls through EVM, voters list

Assam Rifles jawan killed in militant attack in Arunachal; security forces intensify ops to arrest killers

SC slams medicine pricing, calls cancer drug’s 10-fold MRP markup ‘carnage’